We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$122B
$21.5M 0.34%
46,129
+10,070
+28% +$4.84M
GSK icon
52
GSK
GSK
$103B
$21.4M 0.34%
524,000
-976,000
-65% -$39.9M
PARA
53
DELISTED
Paramount Global Class B
PARA
$21.2M 0.34%
+2,000,000
New +$21.8M
WDAY icon
54
Workday
WDAY
$41.8B
$21.1M 0.34%
86,168
-64,308
-43% -$15.2M
REGN icon
55
Regeneron Pharmaceuticals
REGN
$79.9B
$21.1M 0.34%
20,032
+7,968
+66% +$8.87M
XOM icon
56
ExxonMobil
XOM
$631B
$20.9M 0.33%
178,363
-21,985
-11% -$2.54M
NBIX icon
57
Neurocrine Biosciences
NBIX
$16.6B
$20.9M 0.33%
181,381
-797,107
-81% -$109M
NVRO
58
DELISTED
NEVRO CORP.
NVRO
$20.8M 0.33%
3,728,000
+56,000
+2% +$392K
MRK icon
59
Merck
MRK
$319B
$20.8M 0.33%
+182,794
New +$21.7M
GOOGL icon
60
Alphabet (Google) Class A
GOOGL
$4.45T
$20.7M 0.33%
124,707
+8,984
+8% +$1.51M
MSFT icon
61
Microsoft
MSFT
$3.63T
$20.6M 0.33%
47,965
-293
-0.6% -$125K
AMZN icon
62
Amazon
AMZN
$2.95T
$20.6M 0.33%
110,512
+1,718
+2% +$313K
MGNX icon
63
MacroGenics
MGNX
$249M
$20.6M 0.33%
6,258,000
+258,000
+4% +$1.01M
CMG icon
64
Chipotle Mexican Grill
CMG
$44.2B
$20.2M 0.32%
350,818
+225,818
+181% +$12.5M
TMO icon
65
Thermo Fisher Scientific
TMO
$213B
$19.9M 0.32%
32,153
-24,005
-43% -$14.2M
PFGC icon
66
Performance Food Group
PFGC
$17.6B
$19.6M 0.31%
250,325
+9,438
+4% +$661K
TFX icon
67
Teleflex
TFX
$6.16B
$19.3M 0.31%
78,000
+63,000
+420% +$14.7M
HUBS icon
68
HubSpot
HUBS
$12.4B
$19.2M 0.31%
+36,148
New +$18.2M
SKX
69
DELISTED
Skechers
SKX
$18.5M 0.3%
277,161
+58,037
+26% +$3.81M
STAA icon
70
STAAR Surgical
STAA
$1.16B
$18.4M 0.3%
+496,500
New +$18.5M
EL icon
71
Estee Lauder
EL
$31.5B
$18.4M 0.29%
184,472
+2,160
+1% +$205K
SBUX icon
72
Starbucks
SBUX
$121B
$18.3M 0.29%
188,099
-185,151
-50% -$15.9M
NVDA icon
73
NVIDIA
NVDA
$5.33T
$18.3M 0.29%
150,684
+41,853
+38% +$4.94M
GEHC icon
74
GE HealthCare
GEHC
$31.6B
$17.7M 0.28%
+188,913
New +$15.9M
ROST icon
75
Ross Stores
ROST
$81.1B
$17.2M 0.28%
114,312
-22,688
-17% -$3.35M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.